Profound Medical PROF Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $50.3M+8.3% | $59.72M+8.8% | $24.83M— | $35.2M— | $46.43M— | ||
| $9.42M+57.9% | $7.2M+2.2% | $8.17M— | $4.9M— | $5.97M— | ||
| $9M+32.5% | $8.24M+42.0% | $8.34M+2,524% | $8.35M+69,708% | $6.8M+3,675% | ||
| $69.53M+16.1% | $76.09M+10.2% | $41.52M— | $48.81M— | $59.91M— | ||
| $682K+121% | $698K+64.2% | $338K— | $278K— | $309K— | ||
| $129K-39.7% | $138K-47.1% | $123K— | $175K— | $214K— | ||
| $73.46M+20.7% | $77.48M+10.3% | $42.31M— | $49.67M— | $60.86M— | ||
| $2.14M+104% | $1.56M+18.7% | $717K— | $949K— | $1.05M— | ||
| $464K-27.0% | $445K+6.2% | $434K— | $694K— | $636K— | ||
| $4.5M— | —— | $4.48M— | —— | —— | ||
| $10.61M+100% | $6.08M-7.5% | $9.94M— | $5.72M— | $5.3M— | ||
| —— | $4.5M+53.9% | —— | $4.46M— | $4.49M— | ||
| $14.03M+39.3% | $11.04M+12.5% | $10.16M— | $10.41M— | $10.07M— | ||
| $324.16M+15.1% | $323.84M+15.0% | $282.75M— | $281.64M— | $281.64M— | ||
| -$294.79M-15.2% | -$287.74M-17.4% | -$279.57M— | -$271.59M— | -$255.89M— | ||
| $59.42M+17.0% | $66.43M+10.0% | $32.14M+4.6% | $39.26M+0.9% | $50.79M+11.6% | ||
| $73.46M+20.7% | $77.48M+10.3% | $42.31M— | $49.67M— | $60.86M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Profound Medical's total assets?
- Profound Medical (PROF) holds $73.5M in total assets, up 20.7% year over year.
- How much debt does Profound Medical have?
- Profound Medical carries $7.5M in total debt against $59.4M of shareholders' equity, a debt-to-equity ratio of 0.13.
- How much cash does Profound Medical have?
- Profound Medical holds $50.3M in cash and equivalents.
- Can Profound Medical cover its short-term obligations?
- Its current ratio is 6.56 — current assets exceed current liabilities.
- Where does Profound Medical's balance sheet data come from?
- Every line is extracted from Profound Medical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
